MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

MDT

84.12

-0.08%↓

VEEV

226.85

-0.36%↓

A

106.2

-0.66%↓

WBA

11

-0.18%↓

CHE

555.98

+1.76%↑

Search

10X Genomics Inc (Class A)

Slēgts

SektorsVeselības aprūpe

8.27 -0.36

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

8.14

Max

8.27

Galvenie mērījumi

By Trading Economics

Ienākumi

-13M

-49M

Pārdošana

13M

165M

EPS

-0.136

Peļņas marža

-29.71

Darbinieki

1,306

EBITDA

-14M

-38M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+89.52% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2025. g. 8. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

925M

Iepriekšējā atvēršanas cena

8.63

Iepriekšējā slēgšanas cena

8.27

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

10X Genomics Inc (Class A) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 25. apr. 17:01 UTC

Peļņas
Galvenie tirgus virzītāji

Aon Shares Sink After 1Q Profit Falls, Sales Miss Estimates

2025. g. 25. apr. 16:10 UTC

Peļņas
Galvenie tirgus virzītāji

Coursera Shares Rise After 1Q Beat, Better-Than-Expected Revenue View

2025. g. 26. apr. 18:14 UTC

Peļņas

Tech Executives Are Starting to Talk Tariffs. What It May Mean for Apple, Amazon Earnings -- Barrons.com

2025. g. 26. apr. 15:00 UTC

Peļņas
Iegādes, apvienošanās, pārņemšana

Trump 2.0 Era Brings Flurry of Crypto Deals -- WSJ

2025. g. 26. apr. 08:20 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 25. apr. 21:24 UTC

Top Ziņas

Cargo Shipments From China to the U.S. Dwindle -- WSJ

2025. g. 25. apr. 20:50 UTC

Tirgus saruna
Peļņas

Tech, Media & Telecom Roundup: Market Talk

2025. g. 25. apr. 20:45 UTC

Top Ziņas

Stocks Claw Back Most of April's Tariff Losses -- WSJ

2025. g. 25. apr. 20:39 UTC

Peļņas

The Score: Tesla, Capital One, Boeing and More Stocks That Defined the Week -- WSJ

2025. g. 25. apr. 20:37 UTC

Top Ziņas

Trump Administration Lays Out Tariff Roadmap to Streamline Trade Talks -- WSJ

2025. g. 25. apr. 20:19 UTC

Top Ziņas

Nasdaq Climbs More Than 1% as Stocks Finish Strong Week -- WSJ

2025. g. 25. apr. 20:15 UTC

Peļņas

Week's Best: A Dividend Expert's Best Advice -- Barrons.com

2025. g. 25. apr. 19:23 UTC

Tirgus saruna

U.S. Natural Gas Futures Extend Weekly Losses -- Market Talk

2025. g. 25. apr. 19:18 UTC

Tirgus saruna

Oil Futures End Choppy Week With Losses -- Market Talk

2025. g. 25. apr. 18:47 UTC

Tirgus saruna

Gold Extends Pullback to Close Week -- Market Talk

2025. g. 25. apr. 18:39 UTC

Top Ziņas

Nasdaq, Dow Industrials About Flat; Analysts Caution on Trump Tariffs -- WSJ

2025. g. 25. apr. 18:34 UTC

Iegādes, apvienošanās, pārņemšana

Goldman Sachs Upgrades Schwab Stock. Here's Why. -- Barrons.com

2025. g. 25. apr. 18:32 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2025. g. 25. apr. 18:32 UTC

Tirgus saruna
Peļņas

Carriers See Tariffs Driving Up Phone Prices, Slowing Upgrades -- Market Talk

2025. g. 25. apr. 18:08 UTC

Peļņas

Sphere Entertainment Deal Is a Win for Shareholders as Banks Take a Hit -- Barrons.com

2025. g. 25. apr. 17:55 UTC

Tirgus saruna

U.S. Oil Rig Count Rises By 2 to 483 -- Market Talk

2025. g. 25. apr. 17:40 UTC

Top Ziņas

Consumers Continue to Sour on the Economy -- 4th Update

2025. g. 25. apr. 17:38 UTC

Peļņas

Centene Stock Falls on Medicaid Cost Worries -- Barrons.com

2025. g. 25. apr. 17:07 UTC

Tirgus saruna

Oil Futures Turn Higher in Quiet Trade -- Market Talk

2025. g. 25. apr. 16:54 UTC

Tirgus saruna
Peļņas

Mobile Carriers See Stronger Activity on Bigger Price Tags, Tariffs -- Market Talk

2025. g. 25. apr. 16:46 UTC

Peļņas

Reddit, Meta, and Pinterest Stocks Rise. How Alphabet's Earnings Are Giving Them a Boost. -- Barrons.com

2025. g. 25. apr. 16:20 UTC

Tirgus saruna
Peļņas

Basic Materials Roundup: Market Talk

2025. g. 25. apr. 16:12 UTC

Top Ziņas

Dow Industrials Fall; China Plans Economic Support During Trade Battle -- WSJ

2025. g. 25. apr. 16:03 UTC

Peļņas

AbbVie Stock Rises Despite Risks as Earnings Beat Forecasts -- Barrons.com

2025. g. 25. apr. 15:52 UTC

Tirgus saruna

Grains Mixed on Low Volume Trade -- Market Talk

Salīdzinājums

Cenas izmaiņa

10X Genomics Inc (Class A) Prognoze

Cenas mērķis

By TipRanks

89.52% augšup

Prognoze 12 mēnešiem

Vidējais 15.73 USD  89.52%

Augstākais 26 USD

Zemākais 12 USD

Pamatojoties uz 12 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi 10X Genomics Inc (Class A) — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

12 ratings

6

Pirkt

6

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

8.03 / 8.31Atbalsts un pretestība

Īstermiņā

Strong Bullish Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.